Literature DB >> 5921753

Parkinsonism occurring during methyldopa therapy.

R R Strang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5921753      PMCID： PMC1935702     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.

Authors:  M J PEASTON
Journal:  Br Med J       Date:  1964-07-18

2.  METHYLDOPA AND PARKINSONISM.

Authors:  L F PRESCOTT
Journal:  Br Med J       Date:  1964-09-12

3.  Parkinsonism occurring with methyldopa treatment.

Authors:  B M GRODEN
Journal:  Br Med J       Date:  1963-04-13

4.  Dopamine metabolism in Parkinson's disease.

Authors:  M GREER; C M WILLIAMS
Journal:  Neurology       Date:  1963-01       Impact factor: 9.910

5.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

6.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

7.  ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.

Authors:  P L MCGEER; L R ZELDOWICZ
Journal:  Can Med Assoc J       Date:  1964-02-15       Impact factor: 8.262

8.  [The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease].

Authors:  O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1963-05-03       Impact factor: 1.704
  8 in total
  5 in total

1.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

2.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; M Simanyi
Journal:  Dtsch Z Nervenheilkd       Date:  1969

Review 3.  Diagnosis and treatment of Parkinson's disease in the elderly.

Authors:  J I Sage; M H Mark
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

4.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 5.  Parkinson's disease between internal medicine and neurology.

Authors:  Ilona Csoti; Wolfgang H Jost; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-23       Impact factor: 3.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.